Dry eye disease market
Dry Eye Disease Market, By Product Type (Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plugs, and Others), By Formulation Type (Liquid, Gel, Ointment, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Supermarket/Hypermarket, Other Stores, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Apr 2024
- CMI5438
- 163 Pages
- Excel & Pdf
- Pharmaceutical
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Formulation Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
- Market Dynamics
- Global Dry Eye Disease Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 impact on the market
- Global Dry Eye Disease Market, By Product Type, 2019 – 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Cyclosporine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Lifitegrast
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Ocular Lubricant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Punctal Plugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Overview
- Global Dry Eye Disease Market, By Formulation Type, 2019 – 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Liquid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Gel
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Ointment
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Overview
- Global Dry Eye Disease Market, By Distribution Channel, 2019 – 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Supermarket/Hypermarket
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Other Stores
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Overview
- Global Dry Eye Disease Market, By Region, 2019 – 2031, (USD BN)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019–2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation Type, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD BN)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Alcon Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- I-MED Pharma Inc
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novaliq GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lupin
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Otsuka Holdings Co., Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Santen Pharmaceutical Co., Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cambium Medical Technologies
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Viatris Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bausch & Lomb Incorporated
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Abbott
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Adrif Vision
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Grevis Pharmaceuticals Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AFT Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- URSAPHARM Arzneimittel GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Altacor
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Profiles
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
*Browse 32 market data tables and 38 figures on “Dry Eye Disease Market” -Global forecast to 2031
Segmentation
Detailed Segmentation-
- Product Type:
- Cyclosporine
- Corticosteroids
- Lifitegrast
- Ocular Lubricant
- Punctal Plugs
- Others
- Formulation Type:
- Liquid
- Gel
- Ointment
- Others
- Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Supermarket/Hypermarket
- Other Stores
- Online Pharmacies
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Frequently Asked Questions -
What will be the CAGR of the dry eye disease market?
The CAGR of the dry eye disease market is projected to be 8.8% from 2024 to 2031.
What are the major factors driving the dry eye disease market growth?
Increasing product launches and approvals for dry eye disease treatment and increasing usage of computer and mobile screens are the major factors driving the growth of the dry eye disease market.
What are the key factors hampering the growth of the dry eye disease market?
Poor accessibility to eye care services and product recalls are the major factors hampering the growth of the dry eye disease market.
Which is the leading product type in the dry eye disease market?
In terms of product type, cyclosporine is estimated to dominate the market revenue share in 2024.
Which are the major players operating in the dry eye disease market?
Novartis AG, Alcon Inc., I-MED Pharma Inc, Sun Pharmaceutical Industries Ltd., Novaliq GmbH, Cipla Inc., AbbVie Inc., Lupin, Otsuka Holdings Co., Ltd., Santen Pharmaceutical Co., Ltd, Cambium Medical Technologies, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch & Lomb Incorporated, Abbott, Adrif Vision, Grevis Pharmaceuticals Pvt. Ltd., AFT Pharmaceuticals, URSAPHARM Arzneimittel GmbH, and Altacor are the major players.
Which region will lead the dry eye disease market?
North America is expected to lead the dry eye disease market.